_id

690dab1cccc777a4e85d0904

Ticker

AGIO

Name

Agios Pharm

Exchange

NASDAQ

Address

88 Sidney Street, Cambridge, MA, United States, 02139

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.agios.com

Description

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it develops tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and hemolytic anemias; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Last Close

27.46

Volume

1857218

Current Price

27.27

Change

-0.6919155134741488

Last Updated

2025-11-28T11:57:15.021Z

Image

data:image/webp;base64,UklGRmAGAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSNgDAAABmWWI6H+EgfL//2mb5yeZmtguBcpMz5iZmbfTXjsz76+CI92YmRnKyVMIrU6dpg44tvR6LbIL58FPERPAwG3bRu7edtLe/QHiPwUDARC5CAXsguli1JRRGTYDxXW0YZPLUVbh4qIUTxrFZEjLkuealpJEBZoOeVwFeSvW7HB0CR4HBGAERTpFhwScwAEzLrQgy5WjaMMmKbEjhIEWz4Gqv5SUVbUAJI5T+Rsmi04VajokBSKq80zLoEDVqt/lFTg8IUpnGpQiLSHXmj/llYk4og5UlgkzehkU0pIE6latKQhc4BqhnA2fk44dZQ5Xg48jNAaTzZJkUASaavZglQ8gcVTVYBuSpSMAZbEZmIoiR2jJDKbhA18oYY4yj2XQpFEaz1k5hwJREEDwkc6m2bWhpMrHEIaMGde60gTwg1Vv+0nWEgM4MvRIGWQgfJ466QvE06EUPZicZSWuFsanGrbkGleYYtj3qU+sERhh1MZE16EIUJOU0stThS0iOIAEUkRgnwvoFIBr8VSNGeYo0VmmTVI15AEkKIBxQIGAwmLi2ppaYizKUQQIOFwRFioT8Rv02M5zqUUpOT8THBzvYewuB2jQBXyiSwycDzAhjHAbM2/RpBVf+NmKEg8x4iH3UBX9qKxbZWIqhLAcIKEBoS4IVQ/AtYFI0KQMGzXJdOhL2xzyQI3uFneaQG36EUAFxYSO80AogmMAalQ6qh9KJsRoknoNSBsyBjWeTT/70Z88IGneTfB8SZ943ReKhAXMUYsED1CWBF8TpZqzwEQwXEK/EWPGDejY9ZkP/WZbV2sHSDnfsx7h+thLXgVQIbkQFxspBBzDaXoMMrn2HFJkjRmS1seUoJMqpsmxa9mqMgYgRYQAptzuXtfK+MobPvMbgWtMTVSQkNLP0FJzwIOAMk2aMy5DF2hwnJVXUQOQEi6IQvqAadGLHgV+97JXFIQAUjGRwS7GTRlE5KxpEezYL62fSRFqq3NInyiRQ0ARDAdMt3qAnLXsQ9/71bp98ZNVQ0ZkJABXWYWDAQTAeJdQREQXokJ2cLppT3tCL/CFN33qFzVMHMYtONe4mk2/WBa5A0c8oJh7Kt4MzdXucLMLBQryNshdew40MZokWy+bRWpa9hVt2+Hqgou+LUTxXcUGBRVigO1+D7vMJIDrfpdTUBMw9EnJyLJ4tn1J7qoDMdMIjACjRoit4pTLXOAcS8Zp2jx1vg6JLZ66qqJta/LquAhOGChkEGDWnCtc5TxTbArAuQpylv3iN1scIqNT+RugYMl+E6aNSktSSKahZk/JroIaQRKH4J+gAQFWUDggYgIAADAMAJ0BKkAAQAA+tUyfSyckIqGwGAgA4BaJbADSY8yrG05GAr9eoDbG+YDzqvRjvAHPv+w//av+5hDX85fgOx2M+VA9oL0RgK7Idf2ihEcmGbCyI5W0UFR4qZTjB3B2SpzCDkorsTgB1dAA/vytEPJJjdGZUq/2DmPk0W9val9Y6kNEP9WBfpMi3wR+WaNQRzjlDGA7fhWDllSwSM4ZDrFw5srUlWocNzcPzP3buH5w8xuStP/xZVXdbqKN8j0geGtS5Pl0AeMlC17b1aWaRjWgxJ/sna/wmLNh1Fa8vksOCXrKPrWhHlBARmtqX0JbRqndaGueXZjamNPQk4OZXUoS3eidPpw69uSHO9YTXfjHFfMjO9ToNkQi0ICDzwHDKYpRuioEIoufsBuLHXMHvLze8HuH7mKxJvzXIEj+6DzA/Q+5hEYwT+j+14mGQsr52I28fG59TaLj0hyhF7j18qE+ebPymTu/6+7VHw+wVMYQK3GXvM0CZAfEtDxzUj7jRqxJGljN3fFYmAm2R88c2nlzJILAQrWL0fCDq+OOkE6fmW8pNHjJzhABIUMvuKJKvqkkmWj1yzOTI50r1Rz6NYgVcfA0MuMNM9QDmnURy9Ey5o4Rh7I2lOl6dERi5tQ9n8GOER3YaZoSuX4DeNsCmOu4KOwd2J9ct0b31zuMwDdxEobmEgREnouaZ+IvS//nCWvZ+b3nkxCPCqvhNcjLt99ZwUypkF+s+hdWLaE3tBrCGEL6WIdvDpxhEaoGo/t8Y2rwdQuTwf6w69rTQHaWprZ8zQdlVCr/6orM2Yj/KYrAAAA=

Ipo Date

2013-07-24T00:00:00.000Z

Market Cap

1693433216

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.6992470588235294

Sentiment Sources

34

Rating

4

Target Price

32.125

Strong Buy

3

Buy

3

Hold

3

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

12880000

Cost Of Revenue

1679000

Gross Profit

11201000

Operating Expenses

128070000

Operating Income

-116869000

Interest Expense

-

Pretax Income

-103433000

Net Income

-103433000

Eps

-1.7790554911785366

Dividends Per Share

-

Shares Outstanding

58313812

Income Tax Expense

-

EBITDA

-102059000

Operating Margin

-907.3680124223604

Total Other Income Expense Net

13436000

Cash

92710000

Short Term Investments

860150000

Receivables

5029000

Inventories

32034000

Total Current Assets

1033109000

Property Plant Equipment

44325000

Total Assets

1385705000

Payables

19553000

Short Term Debt

17987000

Long Term Debt

-

Total Liabilities

101375000

Equity

1284330000

Depreciation

1374000

Change In Working Capital

-231000

Cash From Operations

-88151000

Capital Expenditures

1555000

Cash From Investing

95555000

Cash From Financing

4435000

Net Change In Cash

11839000

PE

-

PB

1.2344631705169233

ROE

-8.053459780585987

ROA

-7.464287131820986

FCF

-89706000

Fcf Percent

-6.964751552795031

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

4.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

12880000

Quarters > 0 > income Statement > cost Of Revenue

1679000

Quarters > 0 > income Statement > gross Profit

11201000

Quarters > 0 > income Statement > operating Expenses

128070000

Quarters > 0 > income Statement > operating Income

-116869000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-103433000

Quarters > 0 > income Statement > net Income

-103433000

Quarters > 0 > income Statement > eps

-1.7790554911785366

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

58139277

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-102059000

Quarters > 0 > income Statement > operating Margin

-907.3680124223604

Quarters > 0 > income Statement > total Other Income Expense Net

13436000

Quarters > 0 > balance Sheet > cash

92710000

Quarters > 0 > balance Sheet > short Term Investments

860150000

Quarters > 0 > balance Sheet > receivables

5029000

Quarters > 0 > balance Sheet > inventories

32034000

Quarters > 0 > balance Sheet > total Current Assets

1033109000

Quarters > 0 > balance Sheet > property Plant Equipment

44325000

Quarters > 0 > balance Sheet > total Assets

1385705000

Quarters > 0 > balance Sheet > payables

19553000

Quarters > 0 > balance Sheet > short Term Debt

17987000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

101375000

Quarters > 0 > balance Sheet > equity

1284330000

Quarters > 0 > cash Flow > net Income

-103433000

Quarters > 0 > cash Flow > depreciation

1374000

Quarters > 0 > cash Flow > change In Working Capital

-231000

Quarters > 0 > cash Flow > cash From Operations

-88151000

Quarters > 0 > cash Flow > capital Expenditures

1555000

Quarters > 0 > cash Flow > cash From Investing

95555000

Quarters > 0 > cash Flow > cash From Financing

4435000

Quarters > 0 > cash Flow > net Change In Cash

11839000

Quarters > 0 > ratios > PE

-1.7790554911785366

Quarters > 0 > ratios > PB

1.2344631705169233

Quarters > 0 > ratios > ROE

-8.053459780585987

Quarters > 0 > ratios > ROA

-7.464287131820986

Quarters > 0 > ratios > FCF

-89706000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-6.964751552795031

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

12455000

Quarters > 1 > income Statement > cost Of Revenue

2961000

Quarters > 1 > income Statement > gross Profit

9494000

Quarters > 1 > income Statement > operating Expenses

136550000

Quarters > 1 > income Statement > operating Income

-127056000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-112020000

Quarters > 1 > income Statement > net Income

-112020000

Quarters > 1 > income Statement > eps

-1.9336271185317222

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

57932576

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-110761000

Quarters > 1 > income Statement > operating Margin

-1020.1204335608189

Quarters > 1 > income Statement > total Other Income Expense Net

15036000

Quarters > 1 > balance Sheet > cash

80871000

Quarters > 1 > balance Sheet > short Term Investments

858066000

Quarters > 1 > balance Sheet > receivables

4986000

Quarters > 1 > balance Sheet > inventories

30848000

Quarters > 1 > balance Sheet > total Current Assets

1019464000

Quarters > 1 > balance Sheet > property Plant Equipment

47364000

Quarters > 1 > balance Sheet > total Assets

1471237000

Quarters > 1 > balance Sheet > payables

17532000

Quarters > 1 > balance Sheet > short Term Debt

17589000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

101682000

Quarters > 1 > balance Sheet > equity

1369555000

Quarters > 1 > cash Flow > net Income

-112020000

Quarters > 1 > cash Flow > depreciation

1259000

Quarters > 1 > cash Flow > change In Working Capital

8284000

Quarters > 1 > cash Flow > cash From Operations

-77124000

Quarters > 1 > cash Flow > capital Expenditures

875000

Quarters > 1 > cash Flow > cash From Investing

78966000

Quarters > 1 > cash Flow > cash From Financing

65000

Quarters > 1 > cash Flow > net Change In Cash

1907000

Quarters > 1 > ratios > PE

-1.9336271185317222

Quarters > 1 > ratios > PB

1.1535289546750587

Quarters > 1 > ratios > ROE

-8.1792991154061

Quarters > 1 > ratios > ROA

-7.614001007315613

Quarters > 1 > ratios > FCF

-77999000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-6.2624648735447614

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

8726000

Quarters > 2 > income Statement > cost Of Revenue

1085000

Quarters > 2 > income Statement > gross Profit

7641000

Quarters > 2 > income Statement > operating Expenses

114270000

Quarters > 2 > income Statement > operating Income

-106629000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-89289000

Quarters > 2 > income Statement > net Income

-89289000

Quarters > 2 > income Statement > eps

-1.5539602151099046

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

57459000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-105351000

Quarters > 2 > income Statement > operating Margin

-1221.9688287875315

Quarters > 2 > income Statement > total Other Income Expense Net

17340000

Quarters > 2 > balance Sheet > cash

78964000

Quarters > 2 > balance Sheet > short Term Investments

814411000

Quarters > 2 > balance Sheet > receivables

3344000

Quarters > 2 > balance Sheet > inventories

29605000

Quarters > 2 > balance Sheet > total Current Assets

968616000

Quarters > 2 > balance Sheet > property Plant Equipment

50928000

Quarters > 2 > balance Sheet > total Assets

1555518000

Quarters > 2 > balance Sheet > payables

13726000

Quarters > 2 > balance Sheet > short Term Debt

17196000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

88990000

Quarters > 2 > balance Sheet > equity

1466528000

Quarters > 2 > cash Flow > net Income

-89289000

Quarters > 2 > cash Flow > depreciation

1278000

Quarters > 2 > cash Flow > change In Working Capital

-36505000

Quarters > 2 > cash Flow > cash From Operations

-111489000

Quarters > 2 > cash Flow > capital Expenditures

766000

Quarters > 2 > cash Flow > cash From Investing

112587000

Quarters > 2 > cash Flow > cash From Financing

1619000

Quarters > 2 > cash Flow > net Change In Cash

2717000

Quarters > 2 > ratios > PE

-1.5539602151099046

Quarters > 2 > ratios > PB

1.0684466508651727

Quarters > 2 > ratios > ROE

-6.0884620000436405

Quarters > 2 > ratios > ROA

-5.740145726375394

Quarters > 2 > ratios > FCF

-112255000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-12.864428145771258

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

10730000

Quarters > 3 > income Statement > cost Of Revenue

1260000

Quarters > 3 > income Statement > gross Profit

9470000

Quarters > 3 > income Statement > operating Expenses

134507000

Quarters > 3 > income Statement > operating Income

-125037000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-105399000

Quarters > 3 > income Statement > net Income

-96523000

Quarters > 3 > income Statement > eps

-1.68876408426062

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

57156000

Quarters > 3 > income Statement > income Tax Expense

-8876000

Quarters > 3 > income Statement > EBITDA

-123670000

Quarters > 3 > income Statement > operating Margin

-1165.3028890959924

Quarters > 3 > income Statement > total Other Income Expense Net

19638000

Quarters > 3 > balance Sheet > cash

76247000

Quarters > 3 > balance Sheet > short Term Investments

817463000

Quarters > 3 > balance Sheet > receivables

4109000

Quarters > 3 > balance Sheet > inventories

27616000

Quarters > 3 > balance Sheet > total Current Assets

965600000

Quarters > 3 > balance Sheet > property Plant Equipment

54554000

Quarters > 3 > balance Sheet > total Assets

1663199000

Quarters > 3 > balance Sheet > payables

16643000

Quarters > 3 > balance Sheet > short Term Debt

16781000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

122243000

Quarters > 3 > balance Sheet > equity

1540956000

Quarters > 3 > cash Flow > net Income

-96523000

Quarters > 3 > cash Flow > depreciation

1367000

Quarters > 3 > cash Flow > change In Working Capital

-46261000

Quarters > 3 > cash Flow > cash From Operations

-133167000

Quarters > 3 > cash Flow > capital Expenditures

967000

Quarters > 3 > cash Flow > cash From Investing

-49158000

Quarters > 3 > cash Flow > cash From Financing

4842000

Quarters > 3 > cash Flow > net Change In Cash

-177483000

Quarters > 3 > ratios > PE

-1.68876408426062

Quarters > 3 > ratios > PB

1.0114786664901527

Quarters > 3 > ratios > ROE

-6.263838811750627

Quarters > 3 > ratios > ROA

-5.803454667781787

Quarters > 3 > ratios > FCF

-134134000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-12.500838769804288

Quarters > 3 > health Score

34

Valuation > metrics > PE

-1.7790554911785366

Valuation > metrics > PB

1.2344631705169233

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-8.053459780585987

Profitability > metrics > ROA

-10.011818694832781

Profitability > metrics > Net Margin

-8.030512422360248

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.07893220589723825

Risk > metrics > Interest Coverage

-85.05749636098982

Risk > final Score

-280

Risk > verdict

High

Liquidity > metrics > Current Ratio

27.520218433670752

Liquidity > metrics > Quick Ratio

26.666888652104422

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-344

Prev Risks > 1

33

Prev Risks > 2

33

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:12:20.092Z